FTC Suing To Stop Amgen ’s $27.8 Billion Purchase Of Horizon Therapeutics

The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news